Preventive Effect of Naringin on Metabolic Syndrome and Its Mechanism of Action

A Systematic Review

Sivanesan Raja Kumar, Elvy Suhana Mohd Ramli, Nurul Alimah Abdul Nasir, Nafeeza Hj Mohd Ismail, Nur Azlina Mohd Fahami

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Background. Metabolic syndrome (MetS), which consists of cluster of conditions, hypertension, hyperlipidemia, hyperglycemia, and visceral obesity, is affecting population worldwide. Studies have shown that plant derived flavonoids have the ability to alleviate MetS. Naringin is a type of glycoside flavonoid found in most plant and it plays a critical role in the treatment of MetS due to its antioxidant activity and ability to regulate cytokines. Methods. A systematic review was done to study the effects of naringin on the metabolic diseases using electronic databases which include Ovid and Scopus using specific descriptors published from the year 2010 till present to provide updated literature on this field. The articles were assessed and chosen based on the criteria in which the mechanisms and effects of naringin on different metabolic diseases were reported. Results. Thirty-four articles were identified which referred to the studies that correspond to the previously stated criteria. Subsequently after screening for the articles that were published after the year 2010, finally, 19 articles were selected and assessed accordingly. Based on the assessment, naringin could alleviate MetS by reducing visceral obesity, blood glucose, blood pressure, and lipid profile and regulating cytokines. Conclusions. Naringin is an antioxidant that appears to be efficacious in alleviating MetS by preventing oxidative damage and proinflammatory cytokine release. However, the dosage used in animal studies might not be achieved in human trials. Thus, adequate investigation needs to be conducted to confirm naringin's effects on humans.

Original languageEnglish
Article number9752826
JournalEvidence-based Complementary and Alternative Medicine
Volume2019
DOIs
Publication statusPublished - 1 Jan 2019

Fingerprint

Abdominal Obesity
Metabolic Diseases
Cytokines
Flavonoids
Antioxidants
Glycosides
Hyperlipidemias
Hyperglycemia
Blood Glucose
naringin
Databases
Blood Pressure
Hypertension
Lipids
Population
Therapeutics

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

Preventive Effect of Naringin on Metabolic Syndrome and Its Mechanism of Action : A Systematic Review. / Raja Kumar, Sivanesan; Mohd Ramli, Elvy Suhana; Abdul Nasir, Nurul Alimah; Ismail, Nafeeza Hj Mohd; Mohd Fahami, Nur Azlina.

In: Evidence-based Complementary and Alternative Medicine, Vol. 2019, 9752826, 01.01.2019.

Research output: Contribution to journalReview article

@article{f4143ae1ae5542c2ac9f73a7f610ff73,
title = "Preventive Effect of Naringin on Metabolic Syndrome and Its Mechanism of Action: A Systematic Review",
abstract = "Background. Metabolic syndrome (MetS), which consists of cluster of conditions, hypertension, hyperlipidemia, hyperglycemia, and visceral obesity, is affecting population worldwide. Studies have shown that plant derived flavonoids have the ability to alleviate MetS. Naringin is a type of glycoside flavonoid found in most plant and it plays a critical role in the treatment of MetS due to its antioxidant activity and ability to regulate cytokines. Methods. A systematic review was done to study the effects of naringin on the metabolic diseases using electronic databases which include Ovid and Scopus using specific descriptors published from the year 2010 till present to provide updated literature on this field. The articles were assessed and chosen based on the criteria in which the mechanisms and effects of naringin on different metabolic diseases were reported. Results. Thirty-four articles were identified which referred to the studies that correspond to the previously stated criteria. Subsequently after screening for the articles that were published after the year 2010, finally, 19 articles were selected and assessed accordingly. Based on the assessment, naringin could alleviate MetS by reducing visceral obesity, blood glucose, blood pressure, and lipid profile and regulating cytokines. Conclusions. Naringin is an antioxidant that appears to be efficacious in alleviating MetS by preventing oxidative damage and proinflammatory cytokine release. However, the dosage used in animal studies might not be achieved in human trials. Thus, adequate investigation needs to be conducted to confirm naringin's effects on humans.",
author = "{Raja Kumar}, Sivanesan and {Mohd Ramli}, {Elvy Suhana} and {Abdul Nasir}, {Nurul Alimah} and Ismail, {Nafeeza Hj Mohd} and {Mohd Fahami}, {Nur Azlina}",
year = "2019",
month = "1",
day = "1",
doi = "10.1155/2019/9752826",
language = "English",
volume = "2019",
journal = "Evidence-based Complementary and Alternative Medicine",
issn = "1741-427X",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Preventive Effect of Naringin on Metabolic Syndrome and Its Mechanism of Action

T2 - A Systematic Review

AU - Raja Kumar, Sivanesan

AU - Mohd Ramli, Elvy Suhana

AU - Abdul Nasir, Nurul Alimah

AU - Ismail, Nafeeza Hj Mohd

AU - Mohd Fahami, Nur Azlina

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background. Metabolic syndrome (MetS), which consists of cluster of conditions, hypertension, hyperlipidemia, hyperglycemia, and visceral obesity, is affecting population worldwide. Studies have shown that plant derived flavonoids have the ability to alleviate MetS. Naringin is a type of glycoside flavonoid found in most plant and it plays a critical role in the treatment of MetS due to its antioxidant activity and ability to regulate cytokines. Methods. A systematic review was done to study the effects of naringin on the metabolic diseases using electronic databases which include Ovid and Scopus using specific descriptors published from the year 2010 till present to provide updated literature on this field. The articles were assessed and chosen based on the criteria in which the mechanisms and effects of naringin on different metabolic diseases were reported. Results. Thirty-four articles were identified which referred to the studies that correspond to the previously stated criteria. Subsequently after screening for the articles that were published after the year 2010, finally, 19 articles were selected and assessed accordingly. Based on the assessment, naringin could alleviate MetS by reducing visceral obesity, blood glucose, blood pressure, and lipid profile and regulating cytokines. Conclusions. Naringin is an antioxidant that appears to be efficacious in alleviating MetS by preventing oxidative damage and proinflammatory cytokine release. However, the dosage used in animal studies might not be achieved in human trials. Thus, adequate investigation needs to be conducted to confirm naringin's effects on humans.

AB - Background. Metabolic syndrome (MetS), which consists of cluster of conditions, hypertension, hyperlipidemia, hyperglycemia, and visceral obesity, is affecting population worldwide. Studies have shown that plant derived flavonoids have the ability to alleviate MetS. Naringin is a type of glycoside flavonoid found in most plant and it plays a critical role in the treatment of MetS due to its antioxidant activity and ability to regulate cytokines. Methods. A systematic review was done to study the effects of naringin on the metabolic diseases using electronic databases which include Ovid and Scopus using specific descriptors published from the year 2010 till present to provide updated literature on this field. The articles were assessed and chosen based on the criteria in which the mechanisms and effects of naringin on different metabolic diseases were reported. Results. Thirty-four articles were identified which referred to the studies that correspond to the previously stated criteria. Subsequently after screening for the articles that were published after the year 2010, finally, 19 articles were selected and assessed accordingly. Based on the assessment, naringin could alleviate MetS by reducing visceral obesity, blood glucose, blood pressure, and lipid profile and regulating cytokines. Conclusions. Naringin is an antioxidant that appears to be efficacious in alleviating MetS by preventing oxidative damage and proinflammatory cytokine release. However, the dosage used in animal studies might not be achieved in human trials. Thus, adequate investigation needs to be conducted to confirm naringin's effects on humans.

UR - http://www.scopus.com/inward/record.url?scp=85062344397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062344397&partnerID=8YFLogxK

U2 - 10.1155/2019/9752826

DO - 10.1155/2019/9752826

M3 - Review article

VL - 2019

JO - Evidence-based Complementary and Alternative Medicine

JF - Evidence-based Complementary and Alternative Medicine

SN - 1741-427X

M1 - 9752826

ER -